Roshni Rao, MD
Surgical Oncology · New York, NYNPI 1639136963
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $405, 9.3 times the $44 reported in 2019. That places this record below the midpoint for surgical oncology clinicians in NY, where the typical reported total is $1,068.
Across 24 payments — averaging $45.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merit Medical Systems Inc$247
- Impedimed, Inc.$211
- Tactile Systems Technology Inc$133
- AstraZeneca$125
- Smith+Nephew$82
- KUB Technologies Inc.$47
- plus $251 from 8 others
What the payments were for
- Food & beverage$1,05096%
- Entertainment$474%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merit Medical Systems Inc | 2 | $247 |
| Impedimed, Inc. | 1 | $211 |
| Tactile Systems Technology Inc | 6 | $133 |
| AstraZeneca | 1 | $125 |
| Smith+Nephew | 3 | $82 |
| KUB Technologies Inc. | 1 | $47 |
| Dilon Technologies, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Axogen | 1 | $36 |
| Puma Biotechnology, Inc. | 1 | $30 |
| Tempus AI, Inc | 1 | $29 |
| Genentech USA, Inc. | 1 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $23 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Savi SCOUT$247
How this compares
$1,097 in reported general payments places this provider in the 50th percentile of 173 surgical oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in New York
- Sheldon FeldmanNew York$97K
- Kepal PatelNew York$94K
- George PlitasNew York$39K
- James ParkNew York$28K
- Michael LoweNew York$20K
- Scott HananNew York$15K
- Marcovalerio MelisNew York$12K
- Kevin SoaresNew York$10K
- Jennifer CracchioloNew York$9K
- Bert PetersenNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.